focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Funny that at these super bargain levels basu isn't diverting at least half of his very far salary into buying shares on the open market.
I can't believe, after that write up, some buffoons are buying this morning thinking Basu is some sort of tech AIM messiah.
the below is from terminator101 over on advfn.
i see that basu is complaining in the times that the “market dosen’t understand the strategic value of kromek”. when useless directors take to the press to complain about the market it’s worth examining in detail if they have grounds for that complaint. let’s see:
*their last financing “deal” put millions of death spiral finance in place at a high interest rate.
*they have never made a single penny of profit in over a decade.
*directors have barely any skin in the game, the most being 0.7%. hardly backing themselves.
*promise for next year is to be ebitda positive, which means they will make yet another whopping loss.
*two of the directors are creaming more than a quarter of a million in salary every year. that means they have extracted more in salary in a decade than the entire mcap of the company.
strategic value my ****. it’s a crappy aim company run by a bunch of greedy pedestrian scientists, and at £24 million mcap for an enterprise that lost £7 million last year, is massively overvalued. worth at best circa £5 million or less than 1p. it’s a slam dunk short.
Just read this and the attempt at PR knocked by all the comments on his perforrmance.
Basu seems to have been schooled by Bozos Johnson in delusion, self pity and complete lack of self awareness.
Has he been taking lessons from p###o price Andrew or mone?
DYOR and only personal opinion - but suspect many PI's also regret the decision about listing the company!
Article today about Mr Basu's regrets about listing the company.
Had a better relationship with private investors - "very challenging for retail investors to really understand a small, complex business ".
Might encourage more interest in the business?
Nd
Ironknut. I concur.
Billy i think he sold out at 5p when he was coming out with all that big talk. At any event i think he like the BoD will have nothing to say.
Only mick33 can answer that. Wonder what he’s thinking next now. Having said that, I wonder whether he’s even invested.
Come on mick33. Reveal!
Down into the threes.
The problem with having a CEO and senior team who have failed to execute for such an extended period without a break, no news is taken as a bad sign.
Perhaps the overpaid CEO and board would show the way by digging out their piggy banks and buying.
Come on, mick33. Investors are waiting desperately for your advice.
Everyone off loading again.
Can u explain mick33
Yawn indeed Same message as 2018 2019 2020 2021 2022 now 2023. No doubt coming soon in 2024. Only mugs are listening now. Is this person trying to convince himself . Say it often enough and it will come true.
YAWN. @mike33
YAWN. @mke33
New video presentation by Berry Beumer - president - Advanced Imaging Kromek
Watch "CZT in CT and SPECT Imaging" on YouTube
Very clear and informative and shows where Kmk's tech is taking the future of medical imaging.
https://youtu.be/Nny0iJwX5s4?si=h2xIE68UVnuB6GCm
DYOR
Good to do more research as Ironknut mentioned and develop understanding and confidence.
I found this (although old) useful
https://www.equitydevelopment.co.uk/hubfs/Research/Kromek/Kromek%20Group%20%20%20final%20note%20%20%2014th%20July%202021.pdf
Ofcourse lot changed in 2 years but think KMK could continue pull on and in blue, wait seem worth but DYOR
Sill not sure what you are going on about. You seems to be reading some weird technical stuff with no relevance to Kromek. To make it simple for you, read about the wonderful technical breakthrough by Polarean and what it has done for its sp. Boffins + bright ideas does not = Sound share investment. Sorry it is not that simple or easy. Which is why Kromek sp is "in the gutter" and never likely to get out.
Just read this about a large US listed medical imaging solutions provider and Thier intention to focus on Photon counting imaging CT and the size of the addressable Asian markets....CZT based Photon counting tech...bodes well for Kmk I think.
Key takeaways from the earnings call include:
The Medical segment made up 75% of the annual revenues, driven significantly by the global CT market.
Varex's subsidiary, MeVis Medical Solutions, obtained FDA clearance for an AI-based software product, emphasizing the company's focus on photon counting technologies.
The Industrial segment announced the launch of XRpure, an irradiation system for decontaminating organic products, which is expected to add nearly $1 billion to the company's addressable market within five years.
Varex plans to invest in its Industrial segment and expand its use of photon counting technology in medical applications.
Varex Imaging (NASDAQ:VREX) Corporation reported strong fourth quarter and fiscal year 2023 earnings, with Q4 revenue reaching $227 million.
https://uk.investing.com/news/stock-market-news/earnings-call-varex-imaging-reports-solid-q4-2023-results-eyes-expansion-in-india-amid-chinas-challenges-93CH-3238576
Not sure what you are trying to say,but take a look at Polarean and their sp. Then do some research on what they have produced ,in technical terms .Leaves Kromek way behind and then look again at Polarean sp and its history.If you want a silly gamble there are better places to lose your money than Kromek.
"The day after seeing her Prenuvo results, Santarosa had a follow-up CT scan at a local hospital. The nodule was cancerous. She had it removed the following week.".....
"Lacy said Prenuvo's hardware was designed to do "almost as good a job" as contrast by using other techniques."
https://www.cnbc.com/2023/11/10/prenuvo-offers-2500-full-body-mri-scans-that-can-detect-cancer-early.html
@pedro.
You’ve gone quiet, pedro…….
Is everything ok? Or is it the sp trend line proving itself……
I was hoping it would rocket from here based on your blogs alone
A load of waffle.....
if all this was good then it would be hard to buy the shares. Instead, shareholders can't get rid of them quick enough!!!!!
wonder if mick33 has purchased any yet?
Look folks there are Aim companies out there who are miles ahead of Kromek with their technological breakthrough. As for kromek they have been boasting about their wonderful unique dynamic research breakthroughs for more than 5 years. Those claims had the sp at well above 30p. Look at the sp now, pathetic. Nearly everyone is wise to the Smoke and Mirrors. Given their big talk,yet again, there are no takers at more than 5p.. Ask yourselves why When investing, something looks too good to be true, it almost always is.
Super article, thx mike to share and also your comment about 'with assured CZT manufacturing capacity for future production sales', all seem bright as of yet, waiting game but worth